Lockheed Martin Corporation

CVS Health Corporation

AstraZeneca PLC

The largest U.S. bank called such securities the best safe haven for investors

'A once-in-a-generation chance'. Why JPMorgan advises to buy unpopular quality stocks

Century Aluminum Company

Freedom Broker is opening a short-term trade idea on mid-cap aluminum producer Century Aluminum, expecting the stock to gain about 13% over the next two months. The call is based on what the analysts describe as the company’s unique position as a domestic producer of primary aluminum, benefitting from Trump's trade policy and tariff protection.

Freedom short-term trade idea: Buy Century Aluminum as beneficiary of Trump policies

Microsoft Corporation

Oracle Corporation

Cloudflare, Inc.

CrowdStrike Holdings, Inc.

Palo Alto Networks, Inc.

Salesforce, Inc.

The Bank presented a ready-made portfolio with long and short positions

Goldman offered stocks to protect against the "soft-apocalypse." They are growing faster than the S&amp;P 500

Ferrari N.V.

The automaker's stock rose 2 percent in New York - on a day when all three major indexes fell sharply

Ferrari got rid of its latest recommendation to sell shares. What's their potential?

BETA Technologies, Inc.

Shares of mid-cap electric aircraft maker Beta Technologies <a href="https://finance.yahoo.com/quote/BETA/">jumped</a>&nbsp;almost 16% on Wednesday, February 11. The company <a href="https://investors.beta.team/financials/annual-reports/content/0001104659-26-012665/primary_doc.html">disclosed</a>&nbsp;that more than 5% of its shares are owned by technology giant Amazon. At the same time, investment bank Jefferies upgraded the stock to “buy,” which makes Wall Street unanimous in its bullish stance on Beta.

Mid-cap electric airplane maker Beta soars 16% as Jefferies upgrades to 'buy'

Energy Fuels Inc.

Goldman Sachs has&nbsp;<a href="https://www.cnbc.com/2026/02/11/biggest-stocks-wednesday-by-analyst-calls-like-nvidia.html">initiated coverage</a> of mid-cap uranium producer Energy Fuels with a "buy" rating. The company <a href="https://en.oninvest.com/article/beyond-intel-small-energy-defense-stocks-set-to-gain-from-trump-natsec-spending">owns</a>&nbsp;the only U.S. facility capable of processing both conventional uranium and rare earth elements, Goldman Sachs explained.

'Uniquely positioned': Goldman initiates on uranium company Energy Fuels with 'buy'

Relmada Therapeutics, Inc.

In 2025, shares of biotech Relmada Therapeutics surged more than 800%. The company executed a strategic pivot after its lead experimental therapy – a program developed for more than 15 years – <a href="https://www.relmada.com/for-investors/news/detail/306/relmada-therapeutics-reports-that-data-monitoring-committee">failed</a> in clinical trials in December 2024. The setback triggered a <a href="https://finance.yahoo.com/quote/RLMD/">sharp selloff</a> in the stock and raised questions about the company’s ability to continue operations. So why does Wall Street <a href="https://www.marketwatch.com/investing/stock/rlmd/analystestimates?mod=mw_quote_tab">now see</a> as much as 140% upside?

Why Wall Street still sees upside in biotech Relmada after 800% growth in 2025

Viking Therapeutics, Inc.

Novo Nordisk A/S

Eli Lilly and Company

Risk-tolerant investors should not ignore shares of biotech Viking Therapeutics, Motley Fool analyst Adria Cimino <a href="https://www.fool.com/investing/2026/02/11/viking-therapeutics-the-undertheradar-glp1-contend/">argues</a>. This is because the company is developing an obesity drug that could compete with Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound in the near term.

Motley Fool calls Viking the GLP‑1 drugmaker growth-hunting investors 'can't ignore'

Zscaler, Inc.

ServiceNow, Inc.

JPMorgan suggested the three software developer stocks it considers most resilient to the threat of AI

UBS downgraded the U.S. technology sector. Sell or buy shares?

Edgewise Therapeutics, Inc.

Piper Sandler analyst Yasmeen Rahimi has reiterated her "overweight" recommendation on mid-cap biotech Edgewise Therapeutics and called the stock one of the best investment ideas for 2026. She expects the company’s experimental drug to outperform existing treatments in clinical trials, which could give it an advantage in commercialization, the Motley Fool <a href="https://www.fool.com/investing/2026/02/09/why-edgewise-therapeutics-stock-crushed-the-market/">writes</a>.

Why Piper Sandler says biotech Edgewise is a top stock pick in 2026

Samsung Electronics Co., Ltd.

SK hynix Inc.

Micron Technology, Inc.

Tokyo Electron Limited

From Nintendo to Apple suppliers, consumer electronics manufacturers could be affected

'Risk underestimated': memory chip shortage threatens to last longer than investors expect

Americas Gold and Silver Corporation

Kingsgate Consolidated Limited

Gold Resource Corporation

One of the main beneficiaries of the 2025 gold rally was small-cap mining companies. The Small Cap Gold Miner Equal Weight Index, <a href="https://en.oninvest.com/article/gold-fever-small-cap-miners-surging-as-bullion-hits-record-highs">assembled</a>&nbsp;by analyst Aldiyar Anuarbekov specially for&nbsp;Oninvest&nbsp;and including 45 gold producers with market capitalizations of up to $2 billion (see the note on index composition below), soared&nbsp;202.5% in 2025. Meanwhile, the&nbsp;Small Cap Gold Miner Cap Weight Index&nbsp;skyrocketed 208.8% last year.&nbsp;Both indexes significantly outperformed both gold itself and even equities: the precious metal gained 64.5% – its best performance in 46 years – while the S&amp;P 500 added 16.4%.

Investment ideas